What does b.clinic do?

b.clinic is a physiotherapy practice in Brussel. Cooperative, started on 9 May 2018, 2 establishments.

What is the address of b.clinic?

The registered office of b.clinic is located at Kantersteen 47, 1000 Brussel.

Is b.clinic still active?

Yes. According to the CBE (29 October 2026) b.clinic is active, legal situation “Normale toestand”, started on 9 May 2018.

Is b.clinic registered on Peppol?

Yes, b.clinic is registered on the Peppol network with ID 0208:0695864340.

What is the enterprise number of b.clinic?

The enterprise number of b.clinic is BE0695864340.

When was b.clinic founded?

b.clinic was founded on 9 May 2018.

Who are the directors of b.clinic?

According to the 2025 annual accounts, the directors of b.clinic are: Charles-Eric Winandy, Philippe Van Overschelde, Ward Servaes.

Is b.clinic a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 May 2018; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did b.clinic make in 2025?

b.clinic recorded a loss after taxes of € 41,628 in financial year 2025.

What is the revenue of b.clinic?

As a small company, b.clinic is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 67,422.

How much does an employee at b.clinic earn?

The average wage cost per full-time employee at b.clinic was € 64,000 in 2025: staff costs of € 89,575 for 1.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does b.clinic have?

According to the 2025 annual accounts, b.clinic has 1.4 full-time equivalents (FTE).

b.clinic (Cooperative) - Brussel - BE0695864340

Dossier b.clinic, printed on 29 October 2026 from databakkes.be/en/0695864340/b-clinic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Shrinking team NBB

FTE fell two years in a row, from 1.9 to 1.4.

Financials

Financial year 2025

b.clinic from Brussel, company number BE0695864340, closed financial year 2025 with a result of € -41,628 after tax. For that financial year b.clinic recorded a gross margin of € 67,422 and equity of € -551,183. Compared with financial year 2024, the result moved from € 11,954 to € -41,628. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Caution

€ -551,183

▼ € 41,628 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -41,628

▼ still € 11,954 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 15,684

▼ 72% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -569,783.

People and assets in 2025

Full-time equivalents

1.4

▼ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 89,575

▲ 4% vs 2024

€ 64,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,531

▼ 60% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 7,551

▼ 19% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 73,598 Gross margin 2022: € 73,598 First fiscal year in the series	€ 101,162 Gross margin 2023: € 101,162 ▲ 37% vs 2022 (€ 73,598) Favourable step	€ 117,627 Gross margin 2024: € 117,627 ▲ 16% vs 2023 (€ 101,162) Favourable step	€ 67,422 Gross margin 2025: € 67,422 ▼ 43% vs 2024 (€ 117,627) Unfavourable step	▼ 43%
Profit after taxes	€ -91,560 Profit after taxes 2022: € -91,560 First fiscal year in the series	€ -12,289 Profit after taxes 2023: € -12,289 ▲ € 79,271 vs 2022 (€ -91,560) Favourable step	€ 11,954 Profit after taxes 2024: € 11,954 ▲ € 24,244 vs 2023 (€ -12,289) Favourable step	€ -41,628 Profit after taxes 2025: € -41,628 ▼ € 53,582 vs 2024 (€ 11,954) Unfavourable step	▼ € 53,582
Equity	€ -509,220 Equity 2022: € -509,220 First fiscal year in the series	€ -521,510 Equity 2023: € -521,510 ▼ € 12,289 vs 2022 (€ -509,220) Unfavourable step	€ -509,555 Equity 2024: € -509,555 ▲ € 11,954 vs 2023 (€ -521,510) Favourable step	€ -551,183 Equity 2025: € -551,183 ▼ € 41,628 vs 2024 (€ -509,555) Unfavourable step	▼ € 41,628
Total debts	€ 626,612 Total debts 2022: € 626,612 First fiscal year in the series	€ 659,354 Total debts 2023: € 659,354 ▲ 5% vs 2022 (€ 626,612) Unfavourable step	€ 665,048 Total debts 2024: € 665,048 ▲ 1% vs 2023 (€ 659,354) Unfavourable step	€ 671,500 Total debts 2025: € 671,500 ▲ 1% vs 2024 (€ 665,048) Unfavourable step	▲ 1%
Cash	€ 31,658 Cash 2022: € 31,658 First fiscal year in the series	€ 27,247 Cash 2023: € 27,247 ▼ 14% vs 2022 (€ 31,658) Unfavourable step	€ 55,983 Cash 2024: € 55,983 ▲ 105% vs 2023 (€ 27,247) Favourable step	€ 15,684 Cash 2025: € 15,684 ▼ 72% vs 2024 (€ 55,983) Unfavourable step	▼ 72%
Retained profit	€ -527,820 Retained profit 2022: € -527,820 First fiscal year in the series	€ -540,110 Retained profit 2023: € -540,110 ▼ € 12,289 vs 2022 (€ -527,820) Unfavourable step	€ -528,155 Retained profit 2024: € -528,155 ▲ € 11,954 vs 2023 (€ -540,110) Favourable step	€ -569,783 Retained profit 2025: € -569,783 ▼ € 41,628 vs 2024 (€ -528,155) Unfavourable step	▼ € 41,628
Balance sheet total	€ 117,391 Balance sheet total 2022: € 117,391 First fiscal year in the series	€ 137,844 Balance sheet total 2023: € 137,844 ▲ 17% vs 2022 (€ 117,391) Unchanged	€ 155,493 Balance sheet total 2024: € 155,493 ▲ 13% vs 2023 (€ 137,844) Unchanged	€ 120,317 Balance sheet total 2025: € 120,317 ▼ 23% vs 2024 (€ 155,493) Unchanged	▼ 23%
Employees (FTE)	3.4 Employees (FTE) 2022: 3.4 First fiscal year in the series	1.9 Employees (FTE) 2023: 1.9 ▼ 1.5 vs 2022 (3.4) Unchanged	1.6 Employees (FTE) 2024: 1.6 ▼ 0.3 vs 2023 (1.9) Unchanged	1.4 Employees (FTE) 2025: 1.4 ▼ 0.2 vs 2024 (1.6) Unchanged	▼ 0.2

Key figures of b.clinic, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to b.clinic?

What happened at b.clinic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 25, 2026 New annual accounts for financial year 2025: loss of € 41,628 (▼ € 53,582 vs 2024). Source: NBB ↗
May 9, 2018 New establishment in Brussel. KBO
May 9, 2018 New establishment in Gent. KBO
2018 Charles-Eric Winandy became a director. NBB
2018 Philippe Van Overschelde became a director. NBB
2018 Ward Servaes became a director. NBB
May 9, 2018 Start of the company according to the CBE. KBO

In short

From € 91,560 loss in 2022 to € 41,628 loss in 2025.

Paid € 55 in corporate taxes since 2022.

Best year ever: 2024, with € 11,954 profit.

On average € 48,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MoveUP 100%

The stake of MoveUP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

b.clinic

Behind b.clinic are Charles-Eric Winandy, Philippe Van Overschelde and Ward Servaes. The shares are held by MoveUP (100%).

Directors

According to the 2025 annual accounts

Charles-Eric Winandy

Director

Also active at: MoveUP, QUANTEO

since 2018

Philippe Van Overschelde

Director

Also active at: SCALDINO, ORTHOPEDIST DR. VAN OVERSCHELDE HIP KNEE CLINIC DEURLE, CN Concepts, HKC DEURLE, MOG

since 2018

Ward Servaes

Director

since 2018

Shareholders

MoveUP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kantersteen 47

1000 Brussel

2.276.190.617

Kliniekstraat 27

9050 Gent

Active since 9 May 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0695.864.340

VAT number

BE 0695.864.340

Registered office

Kantersteen 47, 1000 Brussel

Names & denominations

b.clinic

Enterprise type

Rechtspersoon

Legal form

Cooperative company

Legal situation

Normale toestand

Start date

9 May 2018

Peppol

Active · Active since 11 Aug 2026

Activities · NACE

Andere ambulante revalidatieactiviteiten

Ambulante revalidatieactiviteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

b.clinic

Warning lights

Financials

What happened to b.clinic?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions